Conjugated linoleic acid (CLA)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Conjugated linoleic acid (CLA), covering 2008-01-16 to 2024-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis [NA]